Frances M. Sladek
Papers
2
Total Citations
42
H-Index
2
About
Frances M. Sladek is a pioneering researcher whose work has fundamentally shaped our understanding of nuclear receptors (NRs) and their role as critical drug targets. Her research focuses on the molecular mechanisms of orphan receptors, coregulators, and the therapeutic potential of these ligand-regulated transcription factors. Sladek’s major contributions include elucidating how NRs control diverse biological and disease processes, from metabolism to cancer, and demonstrating that their regulation by small lipophilic molecules makes them ideal candidates for drug discovery. Her landmark 2003 paper, "Nuclear Receptors as Drug Targets," which has garnered over 40 citations, systematically mapped all 48 NR genes in the human genome, providing a foundational resource for the field. This work has had a lasting impact, guiding the development of targeted therapies for metabolic disorders, inflammatory diseases, and cancers. Sladek’s insights into coregulator interactions have further advanced our ability to design selective modulators, making her a key figure in translational endocrinology and pharmacology. Her research continues to inspire new generations of scientists exploring the therapeutic promise of nuclear receptors.
Research Focus
Key Achievements
Top Papers
- 1
- 2